ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.450
-0.150 (-5.77%)
At close: Feb 20, 2026, 4:00 PM EST
2.440
-0.010 (-0.41%)
After-hours: Feb 20, 2026, 7:17 PM EST
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $321.43 million as of February 20, 2026. Its market cap has increased by 391.48% in one year.
Market Cap
321.43M
Enterprise Value
276.41M
1-Year Change
391.48%
Ranking
Category
Stock Price
$2.45
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $321.43M, a decrease of -69.57%. That is a compound annual growth rate of -19.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 321.43M | 424.65% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 324.79M |
| Candel Therapeutics | 321.16M |
| Aura Biosciences | 320.06M |
| Fennec Pharmaceuticals | 306.36M |
| Aldeyra Therapeutics | 302.02M |
| XOMA Royalty | 301.53M |
| Cabaletta Bio | 301.31M |
| Relmada Therapeutics | 299.20M |